🇺🇸 FDA
Patent

US 6037125

Disruption of the mammalian RAD51 protein and disruption of proteins that associate with mammalian RAD51 for hindering cell proliferation and/or viability of proliferating cells

expired A61KA61K38/00

Quick answer

US patent 6037125 (Disruption of the mammalian RAD51 protein and disruption of proteins that associate with mammalian RAD51 for hindering cell proliferation and/or viability of proliferating cells) held by Lexicon Genetics, Inc. expires Mon Mar 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Lexicon Genetics, Inc.
Grant date
Tue Mar 14 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/00